Australia's most trusted
source of pharma news
Sunday, 24 November 2024
Posted 28 April 2023 AM
CSL Behring's Hemgenix - the first-ever gene therapy for haemophilia B - is among 10 prescription medicine applications recently accepted for review by the TGA.
Hemgenix is currently considered the world's most expensive drug with an eye-popping US$3.5 million (AUD$5.3 million) price tag.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.